Antitumor activity of cordycepin in murine malignant tumor cell line: An in vitro and in silico study

https://doi.org/10.1016/j.molstruc.2023.136946Get rights and content

Highlights

  • Cordycepin is found to be effective against DL cell line.
  • Cordycepin induces significant apoptosis in DL cells, causing cytotoxicity.
  • Cordycepin significantly interacts with anti-apoptotic receptors.
  • Molecular dynamics study confirms cordycepin affinity for anti-apoptotic receptor.

Abstract

Cordycepin, also known as 3′-deoxyadenosine, is a substance similar to adenosine found in the entomopathogenic fungus Cordyceps militaris. This fungus is recognized for its remarkable therapeutic properties. This study seeks to investigate the antitumor activity of cordycepin in Dalton's lymphoma (DL) malignant cancer cell line using cytotoxicity and apoptosis as key parameters. Molecular docking (MD) and molecular dynamic simulation (MDS) were used to further validate the wet lab findings. Cytotoxicity study revealed that cordycepin induced significant cytotoxicity (P ≤ 0.05) in the DL cell line after 24 h of treatment. The efficacy of cordycepin as an apoptotic agent was substantiated by the highly promising results obtained through the apoptotic assay, utilizing the acridine orange/ethidium bromide (AO/EB) dual staining method. Cordycepin interacted with the active sites of antiapoptotic _target proteins (BCL-XL, SURVIVIN, BCL-2, BCL-B, HSP90, and IAP1), as demonstrated by MD study that corroborated the findings of cytotoxicity and apoptotic assays. The comparative examination of docking outcomes indicated that cordycepin exhibits higher affinity for HSP90 in comparison to other _targets. Molecular dynamics simulation for 120 ns further validated the findings of MD as cordycepin remained bound with HSP90 throughout the entire simulation time (120 ns) with favourable binding energy.

Introduction

Cordyceps militaris is an entomopathogenic fungus that grows on the larvae or pupae of insects and it belongs to the phylum Ascomycota, class Sordariomycetes and family Cordycipitaceae [1]. It is locally known as keeda ghas and in China, it is popularly called Dong-Chong-Xia-Cao which translates as winter worm summer grass [2]. In Ayurveda, cordyceps is considered a rasayana herb, which means it is believed to possess rejuvenating properties for prana, the life force. It promotes the well-being of the endocrine system and provides nourishment to the adrenal and reproductive glands. The use of Cordyceps sp. has garnered immense public attention in recent years because of its high price tag and rare availability as it is found at an altitude of approximately 14,000 ft in the Himalayan lands including Nepal, China, Tibet, and India [3,4]. This parasitic mushroom has been well-known in several other traditional medicines for several thousand years for exhibiting a multitude of pharmacological functions such as antioxidant, antitumor, antimetastatic, anti-inflammatory activities, immunopotentiation, immunosuppression, renoprotection, lung and liver protection, etc. [5,6,7,8].
C. militaris has a lot of bioactive compounds that give it medicinal and healing qualities. These include polysaccharides, essential amino acids, fats, flavonoids, phenolic substances, carotenoids, sterols, nucleosides, sterols, proteins, minerals, vitamins, etc. [9,10,4]. One of its potent active compounds, cordycepin or 3′-deoxyadenosine (9-(3-deoxy-β-d-ribofuranosyl) adenine), a nucleoside analogue (Fig. 1) was first extracted from Cordyceps militaris [11]. A purine (adenine) nucleoside and a ribose sugar (ribofuranose) moiety are joined together in the chemical structure of cordycepin via a β-N9-glycosidic bond. The chemical conflation of cordycepin is achieved through the replacement of the OH group at the 3′ position in the ribofuranosyl moiety with H, generating a deoxy analogue of adenosine [5,12]. Within the cellular realm, cordycepin undergoes a remarkable transformation, metamorphosing into 5′ mono-, di-, and tri-phosphates that inhibit the activity of specific enzymes, such as ribose phosphate pyrophosphokinase and 5-phosphoribosyl-1-pyrophosphate amidotransferase, which are used in the de novo biosynthesis of purines [13]. The presence of cordycepin in the cell causes premature termination of transcription due to the inclusion of cordycepin/ 3′-deoxyadenosine instead of adenosine during transcription due to their structural similarities [14]. Cordycepin is reported to possess many biological and pharmacological activities including anticancer, antiviral, immunostimulating activities, antithrombotic, anti-adipogenic, anti-ageing effects, etc. [6,15,16,17]. It is known to interfere with several biochemical and molecular processes, such as purine biosynthesis [13], DNA/RNA synthesis [14], and mTOR (mammalian _target of rapamycin) signaling transduction [18]. Therefore, in the past few decades, extensive research works using cordycepin have been carried out in different countries which has necessitated its large-scale production and this ever-increasing demand is being successfully met by lab based artificial cultivation of C. militaris [19,20]. The artificially grown cordyceps are also reported to show the same promising results and contain almost the same biochemical constituents like the natural ones [21].
Despite the significant role played by cordycepin in the anti-tumor activities the mechanism(s) by which cordycepin inhibits tumor growth is not yet clearly understood [22,23]. Hence, in the present study, the anticancer potential of cordycepin has been reported using cytotoxicity and apoptosis parameters in Dalton's lymphoma (DL) malignant cancer cell line. The findings were supported further by in silico investigations that included molecular docking simulation followed by molecular dynamics. Based on our findings, cordycepin may be a promising pharmacological candidate for the treatment of the most dreadful cancer.

Section snippets

Cell culture and drug preparation

The DL cells were cultured in RPMI/DMEM medium supplemented with a blood product, fetal bovine serum (10% v/v), streptomycin (100 μg/mL), and penicillin (100 U/mL). The cell lines were maintained in a CO2 incubator (Eppendorf, USA) at 37 °C with 5% CO2. Cordycepin (Cat. No: BP0392) was purchased (purity: 98%, HPLC-DAD, 260 nm) from Chengdu Biopurify Phytochemicals Ltd., Wenjiang District, Chengdu, Sichuan Province, China- 611130. To prepare the stock for different doses of cordycepin, 1 mg of

Cell viability assay

The cytotoxicity of cordycepin was evaluated on DL cells by using trypan blue assay and comparing them to a no-treatment control and cisplatin (reference drug). The basic principle of TBE assay is that live cells possess intact cell membranes that exclude the dye whereas in dead cells the dye penetrates into its membranes and shows blue coloured cytoplasm when observed under a light microscope [34]. The DL cells were treated with various concentrations (0.01–1.2 mg/ml) for 24 hrs (Fig. 2). The

Conclusion

The antitumor activities of cordycepin (in vitro) considering cell cytotoxicity study by performing trypan blue assay and apoptosis studies carried out by dual staining method using acridine orange and ethidium bromide (AO/EB) revealed that cordycepin significantly induced cell cytotoxicity in concentration dependent manner in DL cancer cells by causing apoptotic cell death. The molecular docking simulation of cordycepin with antiapoptotic receptor proteins revealed that cordycepin shows

CRediT authorship contribution statement

Jumi Das: Writing – original draft, Investigation. M. Qaiser Fatmi: Software, Formal analysis, Methodology, Conceptualization. Mary Devi: Investigation. Namram Sushindrajit Singh: Data curation, Software, Methodology, Conceptualization. Akalesh Kumar Verma: Supervision, Conceptualization, Methodology, Writing – review & editing.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

Jumi Das acknowledges the Department of Biotechnology (DBT), Government of India for using resources of ongoing DBT project (no. BT/INF/22/SP45376/2022) in the present work. Additionally, we would like to express our gratitude to Cotton University's Faculty of Life Sciences for providing the animal housing facility.

References (54)

  • R. Kumari et al.

    Structural-based virtual screening and identification of novel potent antimicrobial compounds against YsxC of Staphylococcus aureus

    J. Mol. Struct.

    (2022)
  • M.J. Abraham et al.

    GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers

    SoftwareX

    (2015)
  • H. Nath et al.

    Phenanthroline-based Ni (II) coordination compounds involving unconventional discrete fumarate-water-nitrate clusters and energetically significant cooperative ternary π-stacked assemblies: antiproliferative evaluation and theoretical studies

    J. Mol. Struct.

    (2022)
  • S. Choi et al.

    Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor

    Toxicol. Appl. Pharmacol.

    (2011)
  • P. Dhankhar et al.

    Structure of dye-decolorizing peroxidase from Bacillus subtilis in complex with veratryl alcohol

    Int. J. Biol. Macromol.

    (2021)
  • R. Dutta et al.

    GHKL, an emergent ATPase/kinase superfamily

    Trends Biochem. Sci.

    (2000)
  • S.H. McLaughlin et al.

    Independent ATPase activity of Hsp90 subunits creates a flexible assembly platform

    J. Mol. Biol.

    (2004)
  • N. Kang et al.

    Development of high cordycepin-producing Cordyceps militaris strains

    Mycobiology

    (2017)
  • H. Meena et al.

    Estimation of cordycepin by improved HPLC method in the natural and cultured mycelia of high medicinal value Himalayan entomogenous fungus Cordyceps sinensis

    Electron. J. Environ. Agricult. Food Chem.

    (2010)
  • M. Guo et al.

    Comparison of major bioactive compounds of the caterpillar medicinal mushroom, Cordyceps militaris (Ascomycetes), fruiting bodies cultured on wheat substrate and pupae

    Int. J. Med. Mushroom.

    (2016)
  • Y.J. Ahn et al.

    Cordycepin: selective growth inhibitor derived from liquid culture of Cordyceps m ilitaris against clostridium spp

    J. Agric. Food Chem.

    (2000)
  • H. Hur

    Chemical ingredients of Cordyceps militaris

    Mycobiology

    (2008)
  • S. Zhong et al.

    Advances in research of polysaccharides in Cordyceps species

    Food Technol. Biotechnol.

    (2009)
  • K.G. Cunningham et al.

    Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) link

    Nature

    (1950)
  • X. Huichun et al.

    Preparative separation of high-purity cordycepin from Cordyceps militaris (L.) link by high-speed countercurrent chromatography

    J. Liq. Chromatogr. Relat. Technol.

    (2011)
  • F. Rottman et al.

    The Inhibition of Phosphoribosyl-Pyrophosphate Amidotransferase Activity By Cordycepin Monophosphate

    (1964)
  • S. Holbein et al.

    Cordycepin interferes with 3′ end formation in yeast independently of its potential to terminate RNA chain elongation

    RNA

    (2009)
  • View full text